July 18, 2011Open Access

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survival

Key Points

Key points are not available for this paper at this time.

Abstract

Compared with patients in routine clinical practice, PAH detection programs in SSc are able to identify patients with milder forms of the disease, allowing earlier management.

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Humbert et al. (Mon,) studied this question.

synapsesocial.com/papers/69d56ee075589c71d767d75f https://doi.org/https://doi.org/10.1002/art.30541

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era2010 · 1,387 citations
2Changes in causes of death in systemic sclerosis, 1972–20022007 · 1,522 citations
3Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial2008 · 917 citations
4Treatment of Pulmonary Arterial Hypertension2004 · 1,716 citations
5Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach2003 · 765 citations

AI에게 질문

Bookmark

View Full Paper